What's with all the hand-wringing?
We got our wish -- an agressive investor on the board who has expertise in both deal-making and biotech. His mo up to now has been to take a broken company, fix it and sell it for maximum value.
The fixing part is well under way and is reflected in the stock rise from 2. Now we wait for the rest of the fixing... new Iclusig trials, 113, partnerships etc.
The day-to-day fluctuations are irrelevant. If he succeeds, my guess is we will have a steady, slow stock price rise for about a year, followed by a sale. After which he will have established his reputation, independent of Icahn, and we will all be somewhat wealthier (except of course the shorts and those unfortunate longs who lost their nerve during the crash).
